{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T10:20:37Z","timestamp":1794910837757,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key R&D Program of China","award":["2022YFC2702504"],"award-info":[{"award-number":["2022YFC2702504"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871140"],"award-info":[{"award-number":["81871140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Clinical Research Center for Gynecological Diseases","award":["22MC1940200"],"award-info":[{"award-number":["22MC1940200"]}],"id":[{"id":"https:\/\/ror.org\/057tkkm33","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Youth Medical Talents of Shanghai Rising Stars of Medical Talent Youth Development Program","award":["SHWSRS-2023-62"],"award-info":[{"award-number":["SHWSRS-2023-62"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS), in which hyperandrogenism is a major feature, is the most prevalent endocrine disorder among women of reproductive age. Serum free testosterone (FT) reflects the biologically active fraction of circulating testosterone. Accurate assessment of FT allows for precise identification of hyperandrogenism and provides critical guidance for the diagnosis of PCOS. Women with PCOS and normal controls (NCs) were included in this study. Fasting serum samples were collected during the early follicular phase to evaluate key clinical parameters, and FT levels were quantified using liquid chromatography\u2012tandem mass spectrometry (LC\u2012MS\/MS). The diagnostic value of FT for identifying PCOS was assessed using Spearman\u2019s correlation analysis and receiver operating characteristic curves. A total of 202 women were included in the PCOS group, 121 were included in the NC group. Total testosterone (TT), free androgen index (FAI), and FT levels were significantly greater in the PCOS group than in the NC group. Both FAI and FT were positively correlated with body mass index (BMI), triglycerides, low-density lipoprotein cholesterol, fasting insulin and the homeostasis model assessment for insulin resistance; and were negatively correlated with high-density lipoprotein cholesterol. Following age and BMI adjustments, the area under the curve (AUC) for FT (AUC\u2009=\u20090.886) was greater than that for TT (AUC\u2009=\u20090.856) or FAI (AUC\u2009=\u20090.864). Compared with conventional assessments of TT and FAI, LC\u2013MS\/MS\u2013based measurements of FT demonstrate superior diagnostic performance for identifying PCOS. Both FT and FAI are associated with obesity and the features of metabolic syndrome in PCOS patients.<\/jats:p>","DOI":"10.1007\/s43032-026-02146-z","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:44:40Z","timestamp":1785861880000},"page":"2419-2429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Accurate Measurement of Serum Free Testosterone Levels via Liquid Chromatography\u2012Tandem Mass Spectrometry (LC\u2012MS\/MS) has Predictive Value in the Diagnosis of Polycystic Ovary Syndrome and Associated Metabolic Disorders"],"prefix":"10.1007","volume":"33","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaolian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzuo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hefeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-4888","authenticated-orcid":false,"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"4","key":"2146_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. 2025;21(4):230\u201344. https:\/\/doi.org\/10.1038\/s41574-024-01057-w.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2146_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2024;10(1):27. https:\/\/doi.org\/10.1038\/s41572-024-00511-3.","journal-title":"Nat Rev Dis Primers"},{"key":"2146_CR3","doi-asserted-by":"publisher","first-page":"100494","DOI":"10.1016\/j.lanwpc.2022.100494","volume":"25","author":"R Yang","year":"2022","unstructured":"Yang R, Li Q, Zhou Z, Qian W, Zhang J, Wu Z, et al. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg Health West Pac. 2022;25:100494. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100494.","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"2146_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"EA-SPCWG Rotterdam","year":"2004","unstructured":"Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004.","journal-title":"Fertil Steril"},{"issue":"4","key":"2146_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/er.2017-00025","volume":"38","author":"AL Goldman","year":"2017","unstructured":"Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A reappraisal of testosterone\u2019s binding in circulation: physiological and clinical implications. Endocr Rev. 2017;38(4):302\u201324. https:\/\/doi.org\/10.1210\/er.2017-00025.","journal-title":"Endocr Rev"},{"issue":"3","key":"2146_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1210\/edrv-10-3-232","volume":"10","author":"CM Mendel","year":"1989","unstructured":"Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev. 1989;10(3):232\u201374. https:\/\/doi.org\/10.1210\/edrv-10-3-232.","journal-title":"Endocr Rev"},{"key":"2146_CR7","doi-asserted-by":"publisher","first-page":"35539","DOI":"10.1038\/srep35539","volume":"6","author":"MR Laurent","year":"2016","unstructured":"Laurent MR, Hammond GL, Blokland M, Jardi F, Antonio L, Dubois V, et al. Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis. Sci Rep. 2016;6:35539. https:\/\/doi.org\/10.1038\/srep35539.","journal-title":"Sci Rep"},{"issue":"7","key":"2146_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/clinchem\/17.7.585","volume":"17","author":"C Pohlman","year":"1971","unstructured":"Pohlman C, Chen JC, Zorn EM, Wieland RG. Determination of testosterone binding affinity, 17-beta-ol androgens, and free androgen index in hirsute women. Clin Chem. 1971;17(7):585\u20136.","journal-title":"Clin Chem"},{"key":"2146_CR9","doi-asserted-by":"publisher","first-page":"141049","DOI":"10.1016\/j.scitotenv.2020.141049","volume":"745","author":"D Wang","year":"2020","unstructured":"Wang D, Weng Y, Zhang Y, Wang R, Wang T, Zhou J, et al. Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice. Sci Total Environ. 2020;745:141049. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.141049.","journal-title":"Sci Total Environ"},{"key":"2146_CR10","doi-asserted-by":"publisher","first-page":"815968","DOI":"10.3389\/fendo.2022.815968","volume":"13","author":"B Liao","year":"2022","unstructured":"Liao B, Qi X, Yun C, Qiao J, Pang Y. Effects of androgen excess-related metabolic disturbances on granulosa cell function and follicular development. Front Endocrinol (Lausanne). 2022;13:815968. https:\/\/doi.org\/10.3389\/fendo.2022.815968.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2146_CR11","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001.","journal-title":"Mol Metab"},{"issue":"5","key":"2146_CR12","doi-asserted-by":"publisher","first-page":"e249657","DOI":"10.1001\/jamanetworkopen.2024.9657","volume":"7","author":"Z Wang","year":"2024","unstructured":"Wang Z, Jukic AMZ, Baird DD, Wilcox AJ, Li H, Curry CL, et al. Irregular cycles, ovulatory disorders, and cardiometabolic conditions in a US-based digital cohort. JAMA Netw Open. 2024;7(5):e249657. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.9657.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2146_CR13","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s43032-023-01286-w","volume":"30","author":"F Guo","year":"2023","unstructured":"Guo F, Mao S, Long Y, Zhou B, Gao L, Huang H. The influences of perinatal androgenic exposure on cardiovascular and metabolic disease of offspring of PCOS. Reprod Sci. 2023;30(11):3179\u201389. https:\/\/doi.org\/10.1007\/s43032-023-01286-w.","journal-title":"Reprod Sci"},{"key":"2146_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ebiom.2017.01.011","volume":"16","author":"S Tian","year":"2017","unstructured":"Tian S, Lin XH, Xiong YM, Liu ME, Yu TT, Lv M, et al. Prevalence of prediabetes risk in offspring born to mothers with hyperandrogenism. EBioMedicine. 2017;16:275\u201383. https:\/\/doi.org\/10.1016\/j.ebiom.2017.01.011.","journal-title":"EBioMedicine"},{"issue":"3","key":"2146_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/cvr\/cvz180","volume":"116","author":"M Manti","year":"2020","unstructured":"Manti M, Fornes R, Pironti G, McCann Haworth S, Zhengbing Z, Benrick A, et al. Maternal androgen excess induces cardiac hypertrophy and left ventricular dysfunction in female mice offspring. Cardiovasc Res. 2020;116(3):619\u201332. https:\/\/doi.org\/10.1093\/cvr\/cvz180.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2146_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.fertnstert.2013.12.056","volume":"101","author":"WA Salameh","year":"2014","unstructured":"Salameh WA, Redor-Goldman MM, Clarke NJ, Mathur R, Azziz R, Reitz RE. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. Fertil Steril. 2014;101(4):1135\u2013e412. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.056.","journal-title":"Fertil Steril"},{"issue":"3","key":"2146_CR17","doi-asserted-by":"publisher","first-page":"e00267","DOI":"10.1002\/edm2.267","volume":"4","author":"P Simons","year":"2021","unstructured":"Simons P, Valkenburg O, Bons JAP, Stehouwer CDA, Brouwers M. The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome. Endocrinol Diabetes Metab. 2021;4(3):e00267. https:\/\/doi.org\/10.1002\/edm2.267.","journal-title":"Endocrinol Diabetes Metab"},{"issue":"6","key":"2146_CR18","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.fertnstert.2021.07.1203","volume":"116","author":"Y Sun","year":"2021","unstructured":"Sun Y, Li S, Liu H, Bai H, Hu K, Zhang R, et al. Oxidative stress promotes hyperandrogenism by reducing sex hormone-binding globulin in polycystic ovary syndrome. Fertil Steril. 2021;116(6):1641\u201350. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.07.1203.","journal-title":"Fertil Steril"},{"issue":"3","key":"2146_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.fertnstert.2011.06.040","volume":"96","author":"X Zhao","year":"2011","unstructured":"Zhao X, Ni R, Li L, Mo Y, Huang J, Huang M, et al. Defining hirsutism in Chinese women: a cross-sectional study. Fertil Steril. 2011;96(3):792\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.06.040.","journal-title":"Fertil Steril"},{"issue":"6","key":"2146_CR20","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/j.1365-2133.2010.10152.x","volume":"164","author":"JW Lee","year":"2011","unstructured":"Lee JW, Yoo KH, Park KY, Han TY, Li K, Seo SJ, et al. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol. 2011;164(6):1369\u201375. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10152.x.","journal-title":"Br J Dermatol"},{"issue":"5","key":"2146_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4093\/dmj.2021.0220","volume":"45","author":"SY Park","year":"2021","unstructured":"Park SY, Gautier JF, Chon S. Assessment of insulin secretion and insulin resistance in human. Diabetes Metab J. 2021;45(5):641\u201354. https:\/\/doi.org\/10.4093\/dmj.2021.0220.","journal-title":"Diabetes Metab J"},{"issue":"9","key":"2146_CR22","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/humrep\/dead156","volume":"38","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2023;38(9):1655\u201379. https:\/\/doi.org\/10.1093\/humrep\/dead156.","journal-title":"Hum Reprod"},{"issue":"4","key":"2146_CR23","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1530\/EJE-17-0776","volume":"178","author":"M Pugeat","year":"2018","unstructured":"Pugeat M, Plotton I, de la Perriere AB, Raverot G, Dechaud H, Raverot V. Hyperandrogenic states in women: pitfalls in laboratory diagnosis. Eur J Endocrinol. 2018;178(4):R141\u201354. https:\/\/doi.org\/10.1530\/EJE-17-0776.","journal-title":"Eur J Endocrinol"},{"key":"2146_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cca.2015.08.019","volume":"450","author":"HN Bui","year":"2015","unstructured":"Bui HN, Sluss PM, Hayes FJ, Blincko S, Knol DL, Blankenstein MA, et al. Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome. Clin Chim Acta. 2015;450:227\u201332. https:\/\/doi.org\/10.1016\/j.cca.2015.08.019.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"2146_CR25","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2013part 1. Endocr Pract. 2015;21(11):1291\u2013300. https:\/\/doi.org\/10.4158\/EP15748.DSC.","journal-title":"Endocr Pract"},{"issue":"1","key":"2146_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmae028","volume":"31","author":"AD Bizuneh","year":"2025","unstructured":"Bizuneh AD, Joham AE, Teede H, Mousa A, Earnest A, Hawley JM, et al. Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Hum Reprod Update. 2025;31(1):48\u201363. https:\/\/doi.org\/10.1093\/humupd\/dmae028.","journal-title":"Hum Reprod Update"},{"key":"2146_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cca.2017.06.009","volume":"471","author":"SE Karakas","year":"2017","unstructured":"Karakas SE. New biomarkers for diagnosis and management of polycystic ovary syndrome. Clin Chim Acta. 2017;471:248\u201353. https:\/\/doi.org\/10.1016\/j.cca.2017.06.009.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"2146_CR28","doi-asserted-by":"publisher","first-page":"101683","DOI":"10.1016\/j.beem.2022.101683","volume":"36","author":"EC Guzelce","year":"2022","unstructured":"Guzelce EC, Galbiati F, Goldman AL, Gattu AK, Basaria S, Bhasin S. Accurate measurement of total and free testosterone levels for the diagnosis of androgen disorders. Best Pract Res Clin Endocrinol Metab. 2022;36(4):101683. https:\/\/doi.org\/10.1016\/j.beem.2022.101683.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2146_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"Ruth KS, Day FR, Tyrrell J, Thompson DJ, Wood AR, Mahajan A, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26(2):252\u20138. https:\/\/doi.org\/10.1038\/s41591-020-0751-5.","journal-title":"Nat Med"},{"issue":"4","key":"2146_CR30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40618-023-02210-4","volume":"47","author":"F Fruzzetti","year":"2024","unstructured":"Fruzzetti F, Fidecicchi T, Benelli E, Baldari F, Tonacchera M. Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome. J Endocrinol Invest. 2024;47(4):927\u201336. https:\/\/doi.org\/10.1007\/s40618-023-02210-4.","journal-title":"J Endocrinol Invest"},{"key":"2146_CR31","doi-asserted-by":"publisher","first-page":"263349412513841","DOI":"10.1177\/26334941251384195","volume":"19","author":"A Yasmin","year":"2025","unstructured":"Yasmin A, Roychoudhury S, Sengupta P, Ahmed ABF, Ranjan Madhu N, Paul Choudhury A, et al. Prevalence of polycystic ovary syndrome (PCOS) and its associated hormonal and comorbid risk factors in Northeast India: a cross-sectional comparative study. Ther Adv Reprod Health. 2025;19:26334941251384195. https:\/\/doi.org\/10.1177\/26334941251384195.","journal-title":"Ther Adv Reprod Health"},{"key":"2146_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.steroids.2017.12.009","volume":"130","author":"B Echiburu","year":"2018","unstructured":"Echiburu B, Perez-Bravo F, Galgani JE, Sandoval D, Saldias C, Crisosto N, et al. Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome. Steroids. 2018;130:15\u201321. https:\/\/doi.org\/10.1016\/j.steroids.2017.12.009.","journal-title":"Steroids"},{"issue":"9","key":"2146_CR33","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1210\/jc.2017-00947","volume":"102","author":"MW O\u2019Reilly","year":"2017","unstructured":"O\u2019Reilly MW, Kempegowda P, Walsh M, Taylor AE, Manolopoulos KN, Allwood JW, et al. AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(9):3327\u201339. https:\/\/doi.org\/10.1210\/jc.2017-00947.","journal-title":"J Clin Endocrinol Metab"},{"key":"2146_CR34","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf527","author":"RL Rosenfield","year":"2025","unstructured":"Rosenfield RL, Dumesic DA. On the intimate relationship of adiposity to polycystic ovary syndrome. J Clin Endocrinol Metab. 2025. https:\/\/doi.org\/10.1210\/clinem\/dgaf527.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2146_CR35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMra1011035","volume":"371","author":"GI Shulman","year":"2014","unstructured":"Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371(12):1131\u201341. https:\/\/doi.org\/10.1056\/NEJMra1011035.","journal-title":"N Engl J Med"},{"key":"2146_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13048-015-0151-5","volume":"8","author":"D Salilew-Wondim","year":"2015","unstructured":"Salilew-Wondim D, Wang Q, Tesfaye D, Schellander K, Hoelker M, Hossain MM, et al. Polycystic ovarian syndrome is accompanied by repression of gene signatures associated with biosynthesis and metabolism of steroids, cholesterol and lipids. J Ovarian Res. 2015;8:24. https:\/\/doi.org\/10.1186\/s13048-015-0151-5.","journal-title":"J Ovarian Res"},{"issue":"8","key":"2146_CR37","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/humrep\/deaf114","volume":"40","author":"F Tosi","year":"2025","unstructured":"Tosi F, Lando MG, Rosmini F, Lucarini F, Fiorio V, Zanolin ME, et al. Alterations of insulin sensitivity, clearance, and secretion, either alone or in combination, in women with PCOS: impact on metabolic profile and androgenemia. Hum Reprod. 2025;40(8):1550\u201361. https:\/\/doi.org\/10.1093\/humrep\/deaf114.","journal-title":"Hum Reprod"},{"issue":"1","key":"2146_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12958-020-00592-1","volume":"18","author":"J Zhai","year":"2020","unstructured":"Zhai J, Li S, Hu M, Di F, Liu J, Du Y. Decreased brain and muscle ARNT-like protein 1 expression mediated the contribution of hyperandrogenism to insulin resistance in polycystic ovary syndrome. Reprod Biol Endocrinol. 2020;18(1):32. https:\/\/doi.org\/10.1186\/s12958-020-00592-1.","journal-title":"Reprod Biol Endocrinol"},{"key":"2146_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jsbmb.2015.09.003","volume":"154","author":"H Wang","year":"2015","unstructured":"Wang H, Wang X, Zhu Y, Chen F, Sun Y, Han X. Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function. J Steroid Biochem Mol Biol. 2015;154:254\u201366. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.09.003.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2146_CR40","doi-asserted-by":"publisher","unstructured":"Cussen L, McDonnell T, Miller C, McIlroy M, O\u2019Reilly MW. Polycystic ovary syndrome: origins and implications: polycystic ovary syndrome: the impact of androgen excess on metabolic health. Reproduction. 2025;170(2). https:\/\/doi.org\/10.1530\/REP-25-0102.","DOI":"10.1530\/REP-25-0102"},{"key":"2146_CR41","doi-asserted-by":"publisher","first-page":"100420","DOI":"10.1016\/j.jcte.2025.100420","volume":"42","author":"S Benvenga","year":"2025","unstructured":"Benvenga S, Russo M, Fama F, Forte G, Unfer V. Hormone responses to buserelin in polycystic ovary syndrome and in eumenorrheic women with hyperandrogenism\/hyperandrogenemia, and the relationship of these responses with insulin resistance. J Clin Transl Endocrinol. 2025;42:100420. https:\/\/doi.org\/10.1016\/j.jcte.2025.100420.","journal-title":"J Clin Transl Endocrinol"},{"issue":"3","key":"2146_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/cen.13389","volume":"87","author":"M Amiri","year":"2017","unstructured":"Amiri M, Ramezani Tehrani F, Nahidi F, Bidhendi Yarandi R, Behboudi-Gandevani S, Azizi F. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta-regression analysis. Clin Endocrinol (Oxf). 2017;87(3):217\u201330. https:\/\/doi.org\/10.1111\/cen.13389.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2146_CR43","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jamadermatol.2015.4498","volume":"152","author":"TH Schmidt","year":"2016","unstructured":"Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, et al. Cutaneous findings and systemic associations in women with polycystic ovary syndrome. JAMA Dermatol. 2016;152(4):391\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2015.4498.","journal-title":"JAMA Dermatol"},{"key":"2146_CR44","doi-asserted-by":"publisher","unstructured":"Galczynska D, Daniluk J, Buczek-Kutermak A, Prus P, Pluta D. Decoding the relationship between polycystic ovary syndrome and hormonal dependencies of anti-mullerian hormone and other markers. Biomedicines. 2025;13(6). https:\/\/doi.org\/10.3390\/biomedicines13061341.","DOI":"10.3390\/biomedicines13061341"},{"issue":"1","key":"2146_CR45","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-025-04221-9","volume":"23","author":"AD Bizuneh","year":"2025","unstructured":"Bizuneh AD, Kiconco S, Earnest A, Khomami MB, Dhungana RR, Azziz R, et al. The PCOS Phenotypes in Unselected Populations (P-PUP) study: participant clinical features and data harmonization on analysis of individual participant data. BMC Med. 2025;23(1):420. https:\/\/doi.org\/10.1186\/s12916-025-04221-9.","journal-title":"BMC Med"},{"issue":"3","key":"2146_CR46","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jocd.12387","volume":"17","author":"JG Feng","year":"2018","unstructured":"Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. J Cosmet Dermatol. 2018;17(3):511\u20137. https:\/\/doi.org\/10.1111\/jocd.12387.","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"2146_CR47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40257-014-0099-z","volume":"15","author":"S Das","year":"2014","unstructured":"Das S, Reynolds RV. Recent advances in acne pathogenesis: implications for therapy. Am J Clin Dermatol. 2014;15(6):479\u201388. https:\/\/doi.org\/10.1007\/s40257-014-0099-z.","journal-title":"Am J Clin Dermatol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02146-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02146-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02146-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T09:51:12Z","timestamp":1794909072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02146-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2146"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02146-z","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed following the ethical guidelines of the Declaration of Helsinki and was approved by the Ethical Committee of Fudan University Affiliated Obstetrics and Gynecology Hospital (Approval number: No. 2022\u201228). All patients provided signed informed consent forms prior to the commencement of the study.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}